MOTS-c Handling & Storage Protocol

πŸ“„ NovaVitality Peptides β€” Research Use Only (RUO)
Document ID: NV-HSP-MOTSC-2025v1
Effective Date: 09 December 2025
Classification: Internal Research Guidance β€” Not for Clinical or Regulatory Submission


πŸ§ͺ MOTS-c (Mitochondrial ORF-derived Peptide, 16-aa)

Handling, Reconstitution & Storage Protocol

For In Vitro and Preclinical Laboratory Research Use Only

⚠️ WARNING: This protocol applies exclusively to research-grade MOTS-c (Catalogue: NV-MOTSC-10). This material is NOT for human or animal administration. Misuse violates the UK Human Medicines Regulations 2012, FDA 21 CFR §1271, and EU Directive 2001/83/EC.


1. Product Overview

ParameterValue
Peptide NameMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c)
SequenceMRWQENQARGGLGLLG (N-terminal methionine included; amidated C-terminus standard)
Purity (HPLC)β‰₯98% (typical batch: 98.5–99.4%)
Molecular Weight1724.03 g/mol (monoisotopic)
AppearanceWhite to off-white lyophilized powder
SolubilityModerate in acidic aqueous buffers (e.g., 0.1% acetic acid in Hβ‚‚O or 0.9% NaCl); poor in neutral pH water

2. Pre-Handling Safety & Facility Requirements

βœ… Required Before Use:

  • Work within a certified Class II Biological Safety Cabinet (BSC) or laminar flow hood (ISO 5 environment).
  • Wear appropriate PPE: lab coat, nitrile gloves, safety goggles.
  • Ensure access to spill containment kit (absorbent pads, 70% ethanol, biohazard bag).
  • Confirm institutional approval for peptide handling (e.g., local Chemical Hygiene Plan compliance).

🚫 Prohibited:

  • Open vials outside controlled environments.
  • Use in non-sterile or non-research contexts (e.g., personal supplementation).
  • Store near volatile organics, strong oxidizers, or sources of UV light.

3. Reconstitution Procedure

3.1 Recommended Solvents

SolventUse CaseNotes
0.1% Acetic Acid in Sterile WaterStandard for cell culture assaysOptimal solubility; pH β‰ˆ 3.5–4.0
Bacteriostatic Water (0.9% NaCl + 0.9% Benzyl Alcohol)Short-term in vitro work (<72h)Preservative extends shelf-life at 4Β°C; avoid if benzyl alcohol interferes with assay
DMSO (≀10% final conc.)Stock for high-concentration aliquotsUse only for intermediate stocks; dilute β‰₯100-fold into aqueous buffer before biological use

πŸ“Œ Tip: MOTS-c may form transient opalescence upon reconstitution β€” allow 5–10 min at RT with gentle swirling (no vortexing). Sonication (ice bath, 10–15 sec bursts) may aid dissolution.

3.2 Step-by-Step Reconstitution (10mg vial β†’ 1 mg/mL stock)

  1. Centrifuge lyophilized vial briefly (5 sec) to collect powder.
  2. Wipe rubber stopper with 70% ethanol; allow to dry.
  3. Using a sterile syringe, add 10 mL of chosen solvent slowly down the vial wall.
  4. Gently rotate vial for 2–3 min until fully dissolved (no visible particulates).
  5. Aliquot immediately into sterile, low-binding microtubes (e.g., 100 Β΅L Γ— 100 tubes).
  6. Flash-freeze in liquid Nβ‚‚ or dry ice/ethanol bath.
  7. Store per Section 4.

❗ Do not reconstitute entire 10mg vial if single-use doses are smaller β€” partial reconstitution minimises degradation.


4. Storage Recommendations

FormTemperatureDurationStability Notes
Lyophilized (unopened)βˆ’20Β°C, desiccated, darkβ‰₯24 monthsKeep in original amber vial with desiccant
Lyophilized (opened)βˆ’20Β°C, sealed with parafilm + desiccant≀6 monthsMinimise air exposure; purge with argon if possible
Reconstituted (aliquoted, frozen)βˆ’80Β°Cβ‰₯12 monthsAvoid frost-free freezers (temperature cycling degrades peptide)
Reconstituted (refrigerated)2–8Β°C≀7 daysFor bacteriostatic water solutions only; monitor for turbidity

πŸ”¬ Stability Monitoring:

  • Visual check: Discard if cloudiness, precipitation, or colour change (yellow/brown) occurs.
  • For critical assays: Validate activity via pilot dose–response (e.g., AMPK phosphorylation in C2C12 myotubes) if stored >6 months.

5. Handling in Experimental Workflows

  • Cell Culture: Filter-sterilize (0.22 Β΅m PVDF) after reconstitution if not using pre-sterile solvents.
  • In Vivo Rodent Studies: Only use under approved IACUC protocol. Inject within 2h of thawing; keep on ice.
  • Analytical Work (HPLC/MS): Dilute in 0.1% FA in 50:50 ACN:Hβ‚‚O for optimal peak shape. Avoid phosphate buffers (ion suppression).

6. Disposal

Dispose of unused peptide and contaminated materials as chemical-biological mixed waste, per local regulations (e.g., UK: COSHH-compliant hazardous waste stream). Do not pour down the sink.


7. Certificate of Analysis (CoA) & QC

Each batch includes:

  • HPLC Chromatogram (C18, gradient elution)
  • MALDI-TOF or ESI-MS mass confirmation
  • Endotoxin level (typical: <1.0 EU/mg β€” not sterile or pyrogen-free)
  • Water content (KF titration)

πŸ“₯ Request your batch-specific CoA by emailing [email protected] with your order number and catalogue ID.


8. References (Selected Research)

  • Lee et al. (2015). Cell Metabolism 21(3):441–448. (Original MOTS-c discovery)
  • Reynolds et al. (2021). Nature Communications 12:3895. (Mechanism: folate-AMPK axis)
  • Ming et al. (2023). Aging Cell 22(4):e13859. (Age-related metabolic rescue in mice)

πŸ“š For protocol citations, please reference NovaVitality (2025). MOTS-c Handling & Storage Protocol v1.


βœ… Document Prepared By: NovaVitality Ltd
πŸ“§ Contact: [email protected] | 🌐 novavitality.co.uk

Β© 2025 NovaVitality Ltd. All rights reserved. This document is the property of NovaVitality and may not be redistributed without written permission.